Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review

Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Hanmi Pharmaceuticals Co Ltd (Hanmi Pharmaceuticals), a subsidiary of Hanmi Science Co Ltd, develops prescription drugs and over the counter (OTC) drugs. The company’s prescription drugs include antibiotics, antidiarrheal, drugs for osteoporosis, liver supplements, and antiemetics. It provides OTC products such as nutritional supplements, calcium supplement, and vitamins, among others. The products of Hanmi Pharmaceuticals are used in the treatment of cancer, depression, dementia, dermatology, diabetes, inflammation, cardiovascular conditions, epilepsy, hepatitis, osteoarthritis, gastrointestinal diseases, obesity, osteoporosis, and others. The company operates manufacturing facilities in Hwaseong, Songpa and Pyeongtaek, South Korea. It supplies its products and APIs in various countries in Europe, Asia-Pacific, and the Americas. Hanmi Pharmaceuticals is headquartered in Seoul, South Korea.

Hanmi Pharmaceuticals Co Ltd Key Recent Developments

Jan 02,2024: Hanmi Pharmaceutical Appoints In Young Choi (Executive Director) as the Head of the R&D Center
Jan 02,2024: Hanmi Pharmaceutical Confirms Possibility of Developing Innovative New Drugs for Rare Diseases
Oct 16,2023: Successful Launch of JVM''s Next-Generation Automated Drug Dispensing System via High-End Robot Arm ''MENITH'' in the European Market
Apr 27,2023: Hanmi Pharmaceutical Announces 2023 First Quarter Earnings Result

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Hanmi Pharmaceuticals Co Ltd - Key Facts
Hanmi Pharmaceuticals Co Ltd - Key Employees
Hanmi Pharmaceuticals Co Ltd - Major Products and Services
Hanmi Pharmaceuticals Co Ltd - History
Hanmi Pharmaceuticals Co Ltd - Company Statement
Hanmi Pharmaceuticals Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Hanmi Pharmaceuticals Co Ltd - Business Description
Business Segment: Drug Substance
Overview
Performance
Business Segment: Medicine
Overview
Performance
Business Segment: Overseas Medicines
Overview
Performance
Geographical Segment: China
Performance
Geographical Segment: Etc
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Republic of Korea
Performance
Geographical Segment: USA
Performance
R&D Overview
Hanmi Pharmaceuticals Co Ltd - Corporate Strategy
Hanmi Pharmaceuticals Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Hanmi Pharmaceuticals Co Ltd - Strengths
Hanmi Pharmaceuticals Co Ltd - Weaknesses
Hanmi Pharmaceuticals Co Ltd - Opportunities
Hanmi Pharmaceuticals Co Ltd - Threats
Hanmi Pharmaceuticals Co Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 02, 2024: Hanmi Pharmaceutical Appoints In Young Choi (Executive Director) as the Head of the R&D Center
Jan 02, 2024: Hanmi Pharmaceutical Confirms Possibility of Developing Innovative New Drugs for Rare Diseases
Oct 16, 2023: Successful Launch of JVM''s Next-Generation Automated Drug Dispensing System via High-End Robot Arm ''MENITH'' in the European Market
Apr 27, 2023: Hanmi Pharmaceutical Announces 2023 First Quarter Earnings Result
Apr 05, 2023: Hanmi Pharmaceutical, announcing research data on 7 innovative anti-cancer drugs at AACR 2023
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Hanmi Pharmaceuticals Co Ltd, Key Facts
Hanmi Pharmaceuticals Co Ltd, Key Employees
Hanmi Pharmaceuticals Co Ltd, Major Products and Services
Hanmi Pharmaceuticals Co Ltd, History
Hanmi Pharmaceuticals Co Ltd, Other Locations
Hanmi Pharmaceuticals Co Ltd, Subsidiaries
Hanmi Pharmaceuticals Co Ltd, Key Competitors
Hanmi Pharmaceuticals Co Ltd, Ratios based on current share price
Hanmi Pharmaceuticals Co Ltd, Annual Ratios
Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...1)
Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...2)
Hanmi Pharmaceuticals Co Ltd, Interim Ratios
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Hanmi Pharmaceuticals Co Ltd, Performance Chart (2019 - 2023)
Hanmi Pharmaceuticals Co Ltd, Ratio Charts
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Hanmi Pharmaceuticals Co Ltd, Phar

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings